<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) March 24, 1995
--------------------------------
BIOMAGNETICS TECHNOLOGIES, INC.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
California 1-10285 95-2647755
- --------------------------------------------------------------------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
9727 Pacific Heights Boulevard, San Diego, California 92121
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (619) 453-6300
------------------------------
n/a
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report.)
<PAGE>
ITEM 5. OTHER EVENTS.
- ------ ------------
On March 24, 1995, at the annual meeting of shareholders of Biomagnetic
Technologies, Inc. (the "Company"), a majority of the outstanding shares of the
Company voted to approve the proposed issuance and sale of 25,000,000 shares of
common stock of the Company to Dassesta International S.A., a foreign investment
group, for $15,000,000. The shareholders also approved an amendment of the
Company's articles of incorporation to increase the authorized number of shares
of common stock from 23,000,000 to 60,000,000.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
BIOMAGNETIC TECHNOLOGIES, INC.
By: /s/ PETER L. MILLIKIN
--------------------------------------
Peter L. Millikin, Vice President
Date: March 28, 1995
-2-
